Page last updated: 2024-12-08

isoarecolone methiodide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

isoarecolone methiodide: inhibits nicotine binding [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID146968
CHEMBL ID334809
MeSH IDM0151575

Synonyms (7)

Synonym
isoarecolone methiodide
CHEMBL334809 ,
100752-86-1
pyridinium, 4-acetyl-1,2,3,6-tetrahydro-1,1-dimethyl-, iodide
4-acetyl-1,2,3,6-tetrahydro-1,1-dimethylpyridinium iodide
4-acetyl-1,1-dimethyl-1,2,3,6-tetrahydropyridin-1-ium iodide
DTXSID40905722

Research Excerpts

Effects

ExcerptReferenceRelevance
"Isoarecolone methiodide has been reported previously to be a potent agonist at peripheral nicotinic-cholinergic receptors. "( Isoarecolone can inhibit nicotine binding and produce nicotine-like discriminative stimulus effects in rats.
Reavill, C; Spivak, CE; Stolerman, IP; Waters, JA, 1987
)
1.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (12)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Acetylcholine receptor subunit deltaTetronarce californica (Pacific electric ray)EC50 (µMol)0.10000.10000.16670.2000AID145360
Neuronal acetylcholine receptor subunit alpha-3Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.00001.011610.0000AID145658
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.01402.272410.0000AID145658
Neuronal acetylcholine receptor subunit alpha-2Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.10002.104010.0000AID145658
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.01402.310410.0000AID145658
Neuronal acetylcholine receptor subunit beta-3Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.04601.761010.0000AID145658
Neuronal acetylcholine receptor subunit beta-4Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.00001.010110.0000AID145658
Neuronal acetylcholine receptor subunit alpha-5Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.10002.104010.0000AID145658
Neuronal acetylcholine receptor subunit alpha-6Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.04601.761010.0000AID145658
Neuronal acetylcholine receptor subunit alpha-9Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.10002.104010.0000AID145658
Neuronal acetylcholine receptor subunit alpha-7Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.00021.848110.0000AID145658
Neuronal acetylcholine receptor subunit alpha-10Rattus norvegicus (Norway rat)EC50 (µMol)100.00000.10002.104010.0000AID145658
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneNeuronal acetylcholine receptor subunit alpha-9Rattus norvegicus (Norway rat)
plasma membraneNeuronal acetylcholine receptor subunit alpha-10Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID145658Compound was evaluated for functional potency and efficacy at rat Nicotinic acetylcholine receptor in PC12 cells (ganglionic)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID145360Compound was evaluated for functional potency and efficacy at human muscle type Nicotinic acetylcholine receptor in TE671 cells1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.60 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]